Here are five highlights.
1. McKesson will pay $800 million.
2. The deal is expected to close in the first half of McKesson’s fiscal year 2019.
3. MSD’s portfolio of medical supplies, biomedical services and technology solutions serves more than 9,700 healthcare providers at more than 11,000 U.S. locations.
4. New Mountain Capital has owned MSD since 2013.
5. “Combining our complementary businesses will allow us to collectively bring more value to the healthcare providers across the post-acute segments MSD serves,” said MSD CEO Tom Burke.
More articles on supply chain:
McKesson board names new director: 4 key points
Casetabs reaps $6M in series A funding, investment from Nueterra Capital — 5 fast facts
Medtronic’s Infuse Bone Graft wins 3 new indications — 5 insights
